Met-enkephalin modulation of age-related changes in red cell antioxidant status

S Sobocanec1, T Balog, V Sverko

  • 1Division of Molecular Medicine, Rudjer Bosković Institute, Bijenicka 54, 10000 Zagreb, Croatia.

Physiological Research
|February 19, 2005
PubMed

Insights

Methionine-enkephalin (MENK) alters antioxidant enzyme activity in mouse red blood cells, impacting oxidative stress responses. This effect is age-dependent, not sex-dependent, with significant changes observed during the reproductive stage.

Area of Science:

  • Biochemistry
  • Immunology
  • Neuroscience

Background:

  • Opioid peptides, like methionine-enkephalin (MENK), are known modulators of reactive oxygen species (ROS).
  • The mechanism by which MENK influences ROS is not fully understood and is unlikely due to direct scavenger properties.

Purpose of the Study:

  • To investigate the hypothesis that MENK modulates ROS by altering antioxidant enzyme activity (AOE).
  • To examine the age- and sex-related effects of MENK on AOE in mouse red blood cells.

Main Methods:

  • Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX) activities were measured.
  • Red blood cells from CBA mice of varying ages (1, 4, 10, 18 months) and both sexes were analyzed after MENK injection (10 mg/kg).

Main Results:

  • MENK significantly affected AOE in red blood cells in an age-dependent, but not sex-dependent, manner.
  • The most pronounced effects were observed during the reproductive stage.
  • Increased sensitivity to oxidative stress was primarily linked to elevated SOD activity and decreased GPX activity.

Conclusions:

  • MENK modulates antioxidant enzyme activity in mouse red blood cells, influencing oxidative stress.
  • The observed age-related changes suggest a role for MENK in age-associated oxidative stress.
  • Potential deleterious effects of opioid peptides may stem from accumulated hydrogen peroxide (H2O2) due to altered enzyme activity.